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Abstract 
 Atherosclerosis remains one of the major causes of death and premature disability 
in developed countries. It is a chronic inflammatory disease which may cause obstructions of 
the coronary, cerebral and peripheral arteries. The goal of this study to establish association 
age, body mass index and smoking with  severity of coronary artery disease. Seventy eight 
patients (39 males & 39 females) were studied. Seventy eight healthy volunteers match  in 
age and sex were enrolled and accepted as a control group, their age range between (45-75 
years). All patients were admitted to our hospital for elective coronary angiography with  
negative  medical history (hypertension and diabetics mellitus). 
 
Keywords: Relation  between severity of coronary artery disease and body mass index.  
 
Introduction 
Cardiovascular disease (CVS) is the leading cause of mortality worldwide, 
atherosclerosis is the most common form of cardiovascular disease; it usually is 
clinically as the coronary artery disease, peripheral arterial disease (PAD) and 
cerebrovascular disease. The major risk factors are ageing, smoking, alcohol intake, 
hyperlipidemia, diabetes, hypertension, obesity, positive family history. Unhealthy 
diet, sedentary and stressful lifestyle [1].Age is the most potent independent risk 
factor for atherosclerosis. Aging causes changes in the walls of blood vessels, af-
fecting the transport of oxygen and nutrients to the tissues. These changes make 
vessels stiffen, resulting in increased peripheral resistance [2]Over 85% of 
cardiovascular deaths occur in the elderly [3] The most clinically significant 
alterations in cardiovascular physiology with aging are [4]: 
 
a. increased myocardial stiffness. 
b.  increased vascular stiffness.  
c. blunted-adrenoceptormediated modulation of inotropy. 
chronotropy and vasomotor tone, autonomic reflex dysfunction. 
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Hyperlipidemia is a condition when abnormally high levels of lipids often due 
to diet   and life style. This condition is also called hypercholesterolemia/ 
hyperlipoproteinemia [5and6] Most commonly, changes of the serum levels is taken 
as a base in hyperlipidemia diagnosis. The parameters taken into consideration in 
hyperlipidemia diagnosis are total cholesterol(TC), low density lipoprotein-
cholesterol(LDL-C), triglyceride, high density lipoprotein-cholesterol (HDL-C) and 
(very low density lipoprotein)VLDL [7].Smoking is probably the most important 
preventable cause of atherosclerotic vascular disease. There is a strong dependable 
and dose linked, relationship between cigarette smoking and ischemic heart disease, 
Cigarette smoking also acts with other risk factors to greatly increase the risk for 
CHD and exposure to second hand smoke increases the risk of heart disease even for 
nonsmokers [8]. It has a 3 times greater relative risk of developing IC and experience 
symptoms 10 years earlier than their non-smoking counterparts [9].Cigarette smoke 
includes more than 4,000 chemical substances most of which exert a cardiotoxic 
effect [10]. It increases the risk of cardiovascular disease by damaging the 
endothelium lining of the blood vessels, enhancing coagulability and atherogenesis, 
increasing cholesterol plaques and LDL-cholesterol and lowers the HDL-cholesterol 
[11 and 12]. Obesity is a chronic health problem, increasing in the number of people 
worldwide and is now recognized as a global epidemic [13].It is always associated 
with increases in plasma triglycerides. Dyslipidemia includes hypertriglyceridemia, 
reduced HDL cholesterol, and increased numbers of small, dense LDL particles [14] 
It is a true risk factor for cardiovascular disease, whether its impact on vascular risk 
derives solely from interrelations with glucose intolerance, insulin resistance, 
hypertension ,physical inactivity, and dyslipidemia [15].The overweight was defined 
as BMI 25.30 kg/m² for males and females but the obesity was defined as BMI ≥ 30 
kg/m².(BMI) is calculated by dividing the subject's mass by the square of his or her 
height [16and 17].Body mass index is an independent risk factor for CVD, with a risk 
increase of 13% per 5 units increase of BMI [18].Weight control must play a 
fundamental role in all preventive cardiology practices, preferably in conjunction with 
advice regarding diet and exercise 
 
 
Material and Methods 
Study population: A case-control study, was conducted in Shahid AL- Mehrab 
Catheter center. The total number was 156 participants (78 patients with  chronic 
artery disease (patients with acute coronary syndrome excluded from the study)  , and 
underwent elective coronary artery angiography(CAG) in the Catheter Center was 
performed by standard techniques, based on angiographic finding ,the cardiologists 
evaluated each coronary angiography, the patients were classified to the  three groups 
according to the number of obstructed vessels (1, 2&3vessels disease) each group 
consists of  26 patients:13 males &13females, (78) healthy control consists of (39 
males and 39 females) and the all participants gave informed consent. Clinical 
carchatarestics, the severity, and angiographic findings of coronary artery disease 
were reviewed. Clinically a questionnaire was used to collect participant's data that 
includes:  name, age, gender, history of ischemic heart disease, history of PAD, 
tobacco abuse, past medical history (diabetes mellitus and hypertension). 
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Coronary Angiography:  
This was done by specialist interventional cardiologist to appraise extent and 
severity of coronary artery disease, after screening for renal function& hepatitis, C,B 
and human immunsuprreser virus  (HIV) virus, via the femoral approach with 5F or 
6F catheter Omnipaque 300 (iohexol 647mg,trometamol 1.2 mg) was a contrast used 
in all of the cases [20].Significant coronary disease  was defined as at least a 70% 
reduction in the internal diameter of coronary arteries or ≥50% reduction in the 
internal diameter   of left main coronary artery [21] 
 
Methods 
All the patients and control groups were assessed clinically, heamatologically 
and biochemically as fallowing: 
Assessment: 
History 
Full history was taken from each patient regarding personal data like name, age, 
gender, history of IHD. 
 
Body Mass Index(BMI)Measurement: 
Weight and height of patients were measured by the employ of the well 
calibrated digital weight and height scale measuring device, BMI was calculated by 
dividing weight in kilograms by the square of the height in meters as in the equation: 
weight/height (kg/m² [22]. BMI 18.5 to <25 kg/m²  considered normal. The 
overweight was defined as BMI 25.30 kg/m² for males and females but the obesity 
was defined as BMI ≥ 30 kg/m²[23].. 
 
Risk factor assessment 
We examined the following risk factors: hypertension was either self-reported 
or defined as having a systolic blood pressure > 140 /90mmHg or use 
antihypertensive drugs . [24].Diabetic patients in which already on insulin or oral 
hypoglycemic drugs or random plasma glucose >200mg/dl (11.1mmol/l) or fasting 
plasma glucose >126mg/dl(7.0mmol/I) [25].Smoking history was established in 
patients with at least a 10 pack-year history of tobacco use[26] .  
ANOVA test. A p value < 0.05 is considered to be statistically significant and a p 
value < 0.01 considered being highly significant 
 
The Result 
According to the age per years, the patients were classified in to three groups: 
19 patients (45-55) 24.4%, 25 patients(˃55-65) 32% and 34patients(˃65-75) 
43.6%,the height percentage of obstructed vessel disease was seen in patients age 
(˃65-75) (48.7%) of total patient as shown in table(1).Figure (1) describes the 
relationship between CAD and BMI. There is an association of CAD and elevated 
BMI, highly significant (p<0.01) in comparison with the control group for both 
gender. While in the subgroup analysis there is no association between BMI and the 
number of vessels in CAD patients for both gender, P value statistically 
insignificant(p>0.05). Smoking was an important risk factor in CAD, figure (2) 
illustrates that out of 78 patients with obstructed vessel CAD,(43) 55% patients were 
smokers and (35)  45%  patients were nonsmokers as shown in figure( 2). According 
to the result of this study, smoking was important risk factors in CAD. There no 
significant difference  between tobacco abuse and increase in total cholesterol (TC) 
and triglyceride (TG) , on other hand , there is high significant association in increase 
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low density lipoprotein-cholesterol (LDL-C) level and decrease high density 
lipoprotein-cholesterol HDL-C level in CAD  patients   when compared smoker with 
nonsmoker with  (p<0.01) as shown in  figure (3). 
 
Table (1):Relation between number of obstructed vessels  and age per years in 
coronary artery disease patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VD=Vessel Disease 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure(1):  Relation between Severity of Coronary Artery Disease and body mass index(BMI) 
Age per years 
Number of 
obstructed  vessel 
Total ˃65-75 ˃55-65 45-55 
22(28.2%) 10(45.4%) 7(31.8%) 5(22.72%) 
1 vessel 
(Group 1) 
24(30.7%) 11(45.8%) 8(33.3%) 5(20.8%) 
2 vessel 
(Group2) 
32(41%) 17(53%) 12(37.5%) 3(9.3.%) 
3 vessel 
(Group3) 
78 38(48.7%) 27(34.6%). 13(16.6%) Total 
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Figure 2: Percentage of tobacco abuse in coronary artery disease patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3:The relation between tobacco abuse and lipid profile  in coronary artery disease 
patients TC: Total cholesterol, TG: Triglyceride, LDL: Low density lipoprotein and HDL: High 
density lipoprotein 
 
 
Discussion 
The data illustrated in table (1) shows a strong relation between age and severity 
of coronary artery disease(CAD).Same results was reported   [27,28 and 29].Over 
85% of cardiovascular deaths occur in the elderly[30].Aging is the potent independent 
risk factor for atherosclerosis. It causes changes in the walls of blood vessels, af-
fecting the transport of oxygen and nutrients to the tissues. These changes that make 
vessels thicken, results in an increase in peripheral resistance[2] 
In the present study, there is high significant association between body mass 
index (BMI) and coronary artery disease patients(p<0.01) for both gender when 
compared with the control group as presented in figure (1).This result was supported 
by[31, 32and 33]. 
As a consequence of previous the result, obesity is considered an independent 
cardiovascular risk factor that is associated with poor clinical outcomes[31].It is 
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always associated with increases in plasma triglyceride. Dyslipidemia includes 
hypertriglyceridemia, reduced High density lipoprotein- cholesterol(HDL-C), and 
increased numbers of small dense low density lipoprotein(LDL)particles [34]. The 
most worrisome long-term effect of obesity is the increase of atherosclerotic 
cardiovascular disease (ASCVD) and its inherent physical consequences [35].Higher 
body mass index is associated with an increased risk of CAD, cardiovascular events, 
and new-onset heart failure (HF) [36 and 37].The result of this study revealed that a 
high significant decrease in high density lipoprotein-cholesterol(HDL-C) level in 
smoker CAD patients in comparison with non smoker CAD patients figure [43]. 
Similar data  were seen in other studies[35,38,39),40,41and 42]. Contrary to the above 
finding smoking is unrelated to CAD[43 and 44]. Epidemiological data have provided 
broad evidence that low concentrations of HDL-C increased cerebrovascular events. 
[45]Thus, raising high density lipoprotein-cholesterol has become a therapeutic target 
in CAD [46].Smoking increases the concentration of serum low density lipoprotein-
cholesterol (LDL-C), and decreases the levels of antiatherogenic HDL-C 
cholesterol[47,40 and 48]. Cigarette chemical has acrolein, often used in pesticides, 
which affects the way the body processes cholesterol, allowing greater amounts to 
remain in the blood system[49]that leads to damaging vascular endothelium, 
increasing LDL-C oxidation, and lowers the HDL-C[50]. Thus, smoking may exert its 
atherogenic effects through blood lipid levels [51]. 
 
 
Conclusion 
Aging is the potent independent risk factor for atherosclerosis .Tobacco abuse 
with low high density lipoprotein-cholesterol (HDL), increases cardiovascular events 
in compare with non- smokers, therefore induced dyslipidemia and increase risk of 
atherosclerosis. Dyslipidemia (High triglyceride with low HDL levels) surrogates 
markers of atherosclerosis.  Body mass index(BMI) above normal value was an 
independent risk factor associated with CAD.                                                                                             
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ةـــــــصلاــخـــلا 
نييارشلا بلصت ضرم نإ ةقلاع هلو ،ملاعلا ءاحنأ ةفاك يف ةريبك ةلكشم حبصأ .ءانفلاو ةيضرملا ةدايزبهذه نم فدهلا نإ 
نيب ةقلاعلا ىدم ديدحت وه ةساردلا مسجلا ةلتك رشؤم  ضافخناو نينخدملا نيبHDLعافتراوLDL .ةيجاتلا نييارشلا ىضرمل 
 (ةساردلا ةعومجمل يلكلا ددعلا158 (مهنم. كراشم)78باصم ضيرم ) ,ةيجاتلا نييارشلا دادسناب نيمسقم  ددع بسح عيماجم ىلإ
( ةقلغملا نييارشلا1,2,3  نم نوكتت ةتباث هعومجم لك . ) نييارشلا ضارمأ26 , ضيرم13 و لاجر13 ءاسن (  و78 ءاحصأ )
 (  نم نوكتت ةرطيس ةعومجمك39    و لاجر39  رملأ سكا ةعشأ صحف جئاتنو ةدشلا, ةريرسلا تافصلا. ) ءاسن ةيجاتلا نييارشلا ضا
لاا بلقلا ضرم خيرات, سنجلا, رمعلا, مسلاا : نمضتت يتلاو نيكراشملا تانايب عمجل نايبتسا لمع مت ايريرس. اهديدحت مت يتلا,يرافق 
عافترا و ةيجاتلا نييارشلا ضارمأ نيب ام طبارت كلانه.)مدلا طغض عافتراو يركسلا ضرم(يبطلا ضيرملا خيرات, طرفملا نيخدتلا م رشؤ
مسجلا ةلتك,  ضافخناو نينخدملا نيب ام هيوق ةقلاع كلانه HDL عافتراوLDL .ةيجاتلا نييارشلا ىضرمل 
 
 
 
 
 
